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Miscellaneous infections in HIV patients 
-1 Does Ureaplasma Urealyticum Play a 
R. Cultrera, R. Romani', D. Rodand-Dussoix', C. Contini. 
Inferlious Disease, University ofFenara, Fenaru, Italy, 'Dept. Infert and 
~ o p  Dis, Pans, 'Institut Pasteur, Paris 
Objectives: U; urealyticum appears to be involved in respiratory dis- 
ease of preterm infants but is ihquent ly  isolated h m  airways out- 
side the neonatal period. We have retrospectively investigated U 
urealyticum and other mycoplasmas by PCR on BAL and induced 
sputa obtained h m  HIV+ infected patients, in order to assess their 
prevalence in HIV infection. 
Methods: After lysis with buffer containing 120 Fg of proteinase 
Wml, respiratory secretions were directly ampM1ed by PCR. All 
genus- and species-specific primers were mostly deduced h m  either 
the conserved or variable 16s RNA regions; only U urealyticum 
primers were deduced from urease gene. All PCR pmducts were 
electrophorized and visualized by ethidium bromide staining. 
Results: Twelve samples (12%) were positive with genus-specific 
primers and mycoplasmas species were identified on seven samples 
(7%). Among these, there were 1 M.  safioarium + M.  fermentam and 
1 U; urealyticum + M. hominis. The first association was detected in 
one AIDS patient with respiratory symptoms and pulmonary not 
specific mfiltrates. DNA of U urealyticum, together M. hominis, was 
detected in one advanced AIDS patient with past tbc without other 
respiratory symptoms or signs. 
Conclusions: This first detection of U. urealytinrm DNA by PCR 
in respiratory secretions of AIDS patients suggests that its localiza- 
tion in extraurogenital sites during HIV infection may represent the 
outcome of the host's invasion. It could be underestimated because 
of the tkequent failure of culture and serological methods. (Supported 
by grants ofMURST-60% and fondazione CARIFE, Italy) 
Pathogenic Role in HIV Infected Patients? 
I PI476 I Pulmonary and Intestinal Miclosporidiosis 
Caused by Entemcytozoon bieneusi in an AIDS 
Patient 
C. del A g d a  I ,  R. Lopez-Velez ', S. Fenoy 
R. Navajas', G. Visvesvara', A. da Silva3, N. Pieniazek'. 
'University San Pablo, Spain, 'Hospital Ramon y Cajal, Spain, 3CDC, 
Atlanta, USA 
Objectives: Identification of micmsporidia spores in fecal and respira- 
tory samples of an AIDS patient with a two year clinical history of 
intestinal microsporidiosis. 
Methods: Spores from sputum, BAL and feces were character- 
ized by Weber's chromotrope-based stain, IIF and PCR tests. IFA 
was performed by using rabbit anti-Encephalitozoon intestinalis, anti-E. 
hlfem or anti-E. CuninCIi sera. PCR was performed on purified DNA 
from specimens with E. bieneusi-, E. intestinalis-, E. hellem- and E. 
cuniculi-specific primers. 
Results: Stool, BAL and sputum samples contained a variable 
number of spores that stained pinlush red with the Weber's stain 
and measured 0.9 to 1.2 jun. Spores dld not react with any of 
the antisera tested in the IFA assay A diagnostic band of 604-bp 
was observed in the agamse gels when PCR was performed with 
E .  bieneusi speufic primers in fecal and pulmonary samples. No 
amphfication was obtained with the other specific primers in the 
same samples. 
Conclusions: To our knowledge, this is the second reported case 
of E. bieneusi identification in respiratory samples from an AIDS 
patient. Although no pulmonary pathological manifestations of &s 
microsporidia could be established in either case, the colonizing ca- 
C. Turrientes ', 
pability of this organism is now dear and awareness of its possible 
presence in the respiratory tract must be borne in mind for future 
studies, in order to danfy and better understand the pathological 
spectrum of E. bieneusi. 
Peritoneal pneumocystis carinii infection in a 
patient with AIDS A case report and review of 
the literature 
A. Uriel, A.A Hamour, G. Wilson, B. Mandal. UK 
No abstract available. 
[PI478 I Use of lntralesional Interferon Alfa (IFN-a) for 
the Treatment of Recurrent Oral Warts in HIV(+) 
Patients: Report of Three Cases 
E Lozada-Nur ', M. Schubert'. 'University of Cal@rnia San 
Francisco, USA, University of Washington, Seattle, USA 
Objectives: To discuss the clinical responses of recurrent oral warts 
in HIV(+) patients to intralesional injections of IFN-a. 
Methods: The patients were 3 HIV(+) male homosexuals with 
2-3 year hstories of recurrent oral warts who had previously failed 
therapy with cryothemm, electrocautery, laser, topical podophyllum 
25% and/or surgical excision. Lesions were multiple (2-20 each) ver- 
rucoid or flat ranging in size from 0.2 to 0.8 an'; all were asymp- 
tomatic. Other involved sites included anal (one patient) and skin 
(one patient). Patient #1 was treated with total 0.1 ml IFN-a in- 
jected intralesional 2x week for 3 weeks at which point all lesions 
had resolved. He then received one adddonal injection. Patient #2 
was treated 0.5 ml of IFN-a and then with 0.3 ml 4 months later at 
which time there was complete resolution. Patient #3 was treated a 
total of 10 inh-alesional injections with 0.3 ml IFN-a over 3 years. 
He additionally received 2 ml/week IM injections. 
Results: Responses for patient #1 was durable and has persisted 
for over 3 years. patient #2 has remained tke  of lesions for 3 months, 
patient #3 remained under control with ongoing therapy. In patient 
#3 the best result was achleve with a combination of IM and in- 
tralesional interferon. Two patients experienced minor and transient 
adverse side effects (joint pain, alopecia, chills, fever and body ache. 
Side effects were less severe as dose of the medication was lowered. 
Conclusion: Intralesional injection of oral wars with interferon 
alpha appears to provide excellent clinical responses for patients fail- 
ing surgical treatments. 
Doctors' Attitudes Towards HIVIAIDS in the 
Workplace 
V. Duyan', F. A&Iar', I. Sayek2. 'H.U Hospitals Dep. ofsocial 
Work, Turkey, 'H. U. Dep. of General Sutgq, Turkey 
Objective: The main objective of this study is to determine the at- 
titudes of the doctors towards to HIV/AIDS at Hacettepe University 
Hospitals. 
Method: Data were collected h m  self-administered question- 
naire completed anonymously by 128 doctors that are working at the 
H.U. Hospitals. The questionnaire has 19 questions and responses on 
5 scale, 1 = completely agree, 2 = agree, 3 = undeiinite, 4 = dis- 
agree and 5 = completely disagree. The data were analysed using 
SPSS version 5.0. 
Results: T h  study demonstrated that 66.4% of the doctors have 
enough information about HIVIAJDS, but 82.6% of them worry 
getting virus h m  the patients and 55.4% of them are fearful about 
giving treatment to HIV/AIDS patients. 55.5% doctor think that 
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they can be in social contact with HIV/AIDS patients and it is not 
dangerous for other people. 43.0% of the doctor think that they have 
right to refuse to give the treatment. 93.7% of the doctors think that 
special measures to be saved for surgical interventions in HIVIAIDS 
patients. 
Conclusion: Health care professionals, especially doctors are very 
important for giving treatment to the persons with HIV/AIDS. It  
is seen that doctors have positive attitudes towards HIVIAIDS, but 
in some item their attitudes are not clear. In conclusion, it is im- 
portant to understand HIV/AIDS patients in physical, social and 
psychological terms. 
died after a meman time of 6 months (R.: 1-26) h m  the start of 
therapy and after 7 months (R.: 2-43) h m  KS appearance. 
Conclusions: chemotherapy with bleomycin and vincristine in- 
duced a partial and t ime-hted  response in & poor prognosis 
group of patients. 
[El Evaluation of a New Screening Test for the 
Simultaneous Detection of p24 Antigen and 
HIV-1 and HIV-2 Antibodies 
F! Martinez, R. Ortiz de Lejarazu, J.ML Eiros, 
A. Rodriguez-Torres. University Hospital, Valladolid, Spain 
I PI480 I Computer-Assisted Management of an 
Ambulatory HIV Clinic in an University 
Affiliated Hospital 
H. S a x  I ,  F. Fleisch *, A.F. Widmer 
Epidemiology, University Hospital &el, Switzerland, *Kantomspital 
Chur, Switzerland 
Objectives: Treatment options for HIV patients have dramatically 
increased over the last 3 years. Not surprisingly, the medical and 
administrative workload has risen accordingly Financd restrictions 
do not allow to hire the necessary staff. 
The use of computer-assisted programs may fachtate the paper- 
work associated with the care of those patients. 
Methods: We calculated the rise in workload of the single at- 
tending physician of a HIV clinic in a university afKIiated hospital in 
Switzerland during the time period of 1994 and 1996. 
We describe the functionality, features and impact of a computer 
program designed on commercially available software (FileMaker Pro 
2.1, Claris) by the attending physician induding standardized diag- 
nosis and report editors and statistical analysis. 
Results: New admissions in the HIV dinic - and therefore work- 
load - rose 2.9 times benveen 1994 to 1995. The computer program 
allowed to expand the clinic correspondmgly without additional 
medical or secretarial staff. The high quality regarding communi- 
cation with family practitioners and case documentation could be 
maintained. 
Conclusions: The introduction of a computer program helped to 
cope with the rising workload created by the new treatment options 
in HIV patients in a s m a l l  HIV diruc. 
'Division .f Clinical 
[p14811 Treatment of Kaposi's Sarcoma (KS) in HIV 
G. Dassio, A. Maiello, M.M. Calvo, M. Sciandra, G. Meneghin, 
A. Sinicco. Department ofMediull and Surgical Sciences, Section .f 
Infectious Diseases, University .f Turin, Italy 
Objective: to assess efficacy and tolerability of bleomycin and vin- 
cristine in the treatment of KS in patients with HIV infection. 
Methods: h m  01/87 to 11/96, all the patients who presented 
suspected KS lesions undenvent biopsy. If diagnosis was confirmed 
and no previous systemic chemotherapy was performed, the patients 
were enrolled in our study. Vincristine (a bolus dose of 2 mg i.v.) and 
bleomycin (an infusion of 15 mg over 6 h) were administered every 
week. Toxicity was monitored at each scheduled visit. Response to 
therapy was evaluated by clinical criteria. 
Results overall, we enrolled 17 homosexual men [median age: 
35 yr (R.: 22-51); median CD4+ cell count: 84/yL (R.: 3-3341. 
They received a median of 4 week cycles of chemotherapy A partial 
response (reduction of initial lesions) was obtained in 15 (88.2%) 
patients. The most common side-effects were peripheral neuropathy 
(3 cases) and fever (3 cases). During follow-up 15 (88.2%) patients 
infection with Bleomycin and Vincristine 
Objectives: To evaluate a new test, which simultaneously detects 
p24 antigen as well as HIV-1 and HIV-2 envelope antibodies. 
Methods: The new test DECISCAN HIV Ag-Ab (Sanofi Diag- 
nostics Pasteur) is a quahtative enzyme immunoassay whch utilizes 
individual HIV-l/HIV-2 antigens (recombinant HIV-1 gp160, syn- 
thetic peptides representating the inmunodominant region of gp41 
for HIV-1 and gp36 for HIV-2) and anti-p24 monoclonal antibodies 
(murine) immobilized as nitrocelulosa bands on plastic snips. The 
sample volume required is 100 y l  of serum or plasma. The lat is de- 
signed for a fully automated procedure on the DECILAB processor 
system. The reactivity is determinated by comparing the intensity of 
each antigen/monoclonal antibody band to the intensity of the hu- 
man IgG internal control (level +3) and biotinylated bovine serum 
albumin control (level +1) bands on each strip. Sensitivity and es- 
pecificity was evaluated testing 322 serum samples belonging to HIV 
infected (nVIH-] = 182; nVIH-2 = 2), seronegative subjects with risk 
factors for HIV infecti6n (n = 52), multitranshed (n = 40) and 
healthy blood donors (n = 46). The reference techniques for HIV 
antibodies and p24 antigen were Western blot (Bioblot HIV plus, 
Genelabs Diagnostic) and an enzyme immunoassay (ELAVIA Ag I, 
Sanofi Diagnotics Pasteur) respectively 
Results: The results for p24 antigen and HIV 1/2 antibodies 
show 99.9% sensitivity and 94.2% spechcity. Seroconversion results 
show that the new test detected p24 antigen as soon as p24 antigen 
was detected by reference technique. 
Conclusions: The simultaneous detection of p24 antigen and 
HIV antibodies decreases the time lapse between HIV primoinfec- 
tion and diagnosis of infection. 
